Harnessing the Horse for Human Osteoarthritis: microRNA‐181a‐5p Antisense Oligonucleotides in Clinically Normal Equine Fetlock Joints Are Safe and Well Tolerated
Journal of Orthopaedic Research · 2026-11 · 44 (11)
DOI: 10.1002/jor.70298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 24.10.2026. Verfasst von T Connor McCorkell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Osteoarthritis, MicroRNAs, Oligonucleotides, Antisense. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Krembil Foundation, Tony and Shari Fell Platinum Chair in Arthritis Research.
Abstract (Originalsprache)
Horses serve as a translational model for human osteoarthritis (OA) due to their comparable joint size, cartilage thickness, and incidence of naturally occurring disease. Overexpression of microRNA‐181a‐5p has been implicated in cartilage degradation in OA, and its inhibition using locked nucleic acid antisense oligonucleotides (LNA‐miR‐181a‐5p ASOs) represents a potential therapeutic strategy. This study evaluated the safety of intraarticular (IA) LNA‐miR‐181a‐5p ASO injection in clinically normal horse fetlock joints. Twelve horses were randomized to receive two IA injections, 28 days apart, of either low‐dose [2000 µg ( n = 6)] or high‐dose [4000 µg ( n = 6)] LNA‐miR‐181a‐5p ASO. Over 56 days, variables assessed included physical examinations, joint assessments (effusion, circumference, temperature), lameness scores, and biofluid analyses. Physical and lameness evaluation variables remained similar to baseline and did not differ by dose ( p > 0.05). Joint effusion was mildly increased in high‐dose joints at Day 3 post‐injection ( p < 0.05), while circumference, temperature, and hematologic and biochemical variables remained similar to baseline, and did not differ by dose ( p > 0.05). A transient, dose‐independent increase ( p < 0.05) in nucleated cell count at day 3 following each injection was observed, consistent with post‐arthrocentesis inflammation. Synovial fluid IL‐1β and PGE 2 concentrations did not differ across doses and timepoints ( p > 0.05). Although TNF‐α concentrations were greater in the high‐dose group ( p < 0.05), values were variable across horses, even prior to treatment. Overall, IA LNA‐miR‐181a‐5p ASO was well tolerated in clinically normal horse fetlocks, with only transient inflammatory changes, supporting its evaluation as a potential OA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
ORCID-Profile: T Connor McCorkell, Rodrigo Munevar Luque, Janet Beeler-Marfisi, Jonathan Lamarre, Judith B Koenig
Förderung
- CIHR
- Krembil Foundation
- Tony and Shari Fell Platinum Chair in Arthritis Research
- Canadian Institutes of Health Research
Zitieren
APA
Connor McCorkell, T., Mortagy, N., Luque, R. M., Koch, T. G., Beeler-Marfisi, J., Raja Rampersaud, Y., Lamarre, J., Kapoor, M., & Koenig, J. B. (2026). Harnessing the Horse for Human Osteoarthritis: microRNA‐181a‐5p Antisense Oligonucleotides in Clinically Normal Equine Fetlock Joints Are Safe and Well Tolerated. Journal of Orthopaedic Research, 44(11). https://doi.org/10.1002/jor.70298
Vancouver
Connor McCorkell T, Mortagy N, Luque RM, Koch TG, Beeler-Marfisi J, Raja Rampersaud Y, et al. Harnessing the Horse for Human Osteoarthritis: microRNA‐181a‐5p Antisense Oligonucleotides in Clinically Normal Equine Fetlock Joints Are Safe and Well Tolerated. Journal of Orthopaedic Research. 2026;44(11). doi:10.1002/jor.70298
BibTeX
@article{ConnorMcCorkell2026,
author = {Connor McCorkell, T and Mortagy, Narman and Luque, Rodrigo Munevar and Koch, Thomas G and Beeler-Marfisi, Janet and Raja Rampersaud, Y and Lamarre, Jonathan and Kapoor, Mohit and Koenig, Judith B},
title = {Harnessing the Horse for Human Osteoarthritis: microRNA‐181a‐5p Antisense Oligonucleotides in Clinically Normal Equine Fetlock Joints Are Safe and Well Tolerated},
journal = {Journal of Orthopaedic Research},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/jor.70298}
}
EUVIMED